VIROLOGIC, INC.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 26, 2009 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 540 Total Citation Count
- Jul 30, 1998 Earliest Filing
- 19 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2006/0094,020 Methods and compositions for determining resistance or susceptibility of HIV-1 to stavudineAbandonedOct 29, 04May 04, 06[C12Q]
2006/0035,249 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSAbandonedMay 27, 05Feb 16, 06[C12Q]
2005/0214,749 Method for determining reduced susceptibility of HIV to protease inhibitor treatmentAbandonedFeb 04, 05Sep 29, 05[C12Q]
2005/0214,750 Compositions and methods for determining the replication capacity of a pathogenic virusAbandonedFeb 04, 05Sep 29, 05[C12Q, G01N, G06F]
2005/0214,752 Compositions and methods for determining epistatic relationships between HIV mutations that affect replication capacityAbandonedMar 28, 05Sep 29, 05[C12Q]
2005/0130,134 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment HIV-AIDSAbandonedNov 15, 04Jun 16, 05[C12Q]
2005/0074,888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the sameAbandonedNov 25, 03Apr 07, 05[C12N]
2004/0063,191 Compositions and methods for determining the replication capacity of a pathogenic virusAbandonedJul 01, 03Apr 01, 04[C12N]
2003/0108,857 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSAbandonedJun 04, 01Jun 12, 03[C12Q]
2003/0028,011 Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugsAbandonedMay 03, 02Feb 06, 03[C07H, C12Q, C12N]
2003/0013,079 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the sameAbandonedJun 21, 01Jan 16, 03[A61K, C12Q, C12P, C12N]
2002/0034,732 COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL DRUG SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL DRUG SCREENINGAbandonedJul 30, 98Mar 21, 02[C12Q, C12P, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.